These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 21913016)
1. High serum hyaluronic acid and HBV viral load are main prognostic factors of local recurrence after complete radiofrequency ablation of hepatitis B-related small hepatocellular carcinoma. Xia F; Lai EC; Lau WY; Ma K; Li X; Bie P; Qian C Ann Surg Oncol; 2012 Apr; 19(4):1284-91. PubMed ID: 21913016 [TBL] [Abstract][Full Text] [Related]
2. Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy. Chung GE; Kim W; Lee JH; Kim YJ; Yoon JH; Lee JM; Lee JY; Kim SH; Kim D; Lee HS J Gastroenterol Hepatol; 2011 Nov; 26(11):1638-45. PubMed ID: 22011297 [TBL] [Abstract][Full Text] [Related]
3. High viral load is associated with poor overall and recurrence-free survival of hepatitis B virus-related hepatocellular carcinoma after curative resection: a prospective cohort study. Yang T; Lu JH; Zhai J; Lin C; Yang GS; Zhao RH; Shen F; Wu MC Eur J Surg Oncol; 2012 Aug; 38(8):683-91. PubMed ID: 22621971 [TBL] [Abstract][Full Text] [Related]
4. Recurrence of hepatitis B-related hepatocellular carcinoma is associated with high viral load at the time of resection. Hung IF; Poon RT; Lai CL; Fung J; Fan ST; Yuen MF Am J Gastroenterol; 2008 Jul; 103(7):1663-73. PubMed ID: 18616655 [TBL] [Abstract][Full Text] [Related]
5. Early viral suppression predicts good postoperative survivals in patients with hepatocellular carcinoma with a high baseline HBV-DNA load. Huang G; Yang Y; Shen F; Pan ZY; Fu SY; Lau WY; Zhou WP; Wu MC Ann Surg Oncol; 2013 May; 20(5):1482-90. PubMed ID: 23247982 [TBL] [Abstract][Full Text] [Related]
6. The impact of hepatitis B viral load on recurrence after complete necrosis in patients with hepatocellular carcinoma who receive transarterial chemolipiodolization: implications for viral suppression to reduce the risk of cancer recurrence. Jang JW; Choi JY; Bae SH; Yoon SK; Woo HY; Chang UI; Kim CW; Nam SW; Cho SH; Yang JM; Lee CD Cancer; 2007 Oct; 110(8):1760-7. PubMed ID: 17724708 [TBL] [Abstract][Full Text] [Related]
7. Predisposing factors for recurrence of HBV-related small hepatocellular carcinoma after percutaneous radiofrequency ablation. Sohn W; Paik YH; Lee MW; Rhim H; Lim HK; Cho JY; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC Scand J Gastroenterol; 2014 Mar; 49(3):373-80. PubMed ID: 24354931 [TBL] [Abstract][Full Text] [Related]
8. High hepatitis B virus DNA level in serum before liver transplantation increases the risk of hepatocellular carcinoma recurrence. Li MR; Chen GH; Cai CJ; Wang GY; Zhao H Digestion; 2011; 84(2):134-41. PubMed ID: 21502763 [TBL] [Abstract][Full Text] [Related]
9. Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma. Sun HC; Zhang W; Qin LX; Zhang BH; Ye QH; Wang L; Ren N; Zhuang PY; Zhu XD; Fan J; Tang ZY J Hepatol; 2007 Nov; 47(5):684-90. PubMed ID: 17854945 [TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus reactivation after radiofrequency ablation or hepatic resection for HBV-related small hepatocellular carcinoma: a retrospective study. Dan JQ; Zhang YJ; Huang JT; Chen MS; Gao HJ; Peng ZW; Xu L; Lau WY Eur J Surg Oncol; 2013 Aug; 39(8):865-72. PubMed ID: 23597497 [TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in hepatitis C patients with a single small hepatocellular carcinoma after radiofrequency ablation. Toshikuni N; Takuma Y; Goto T; Yamamoto H Hepatogastroenterology; 2012; 59(120):2361-6. PubMed ID: 23169175 [TBL] [Abstract][Full Text] [Related]
12. The effect of long-term supplementation with branched-chain amino acid granules in patients with hepatitis C virus-related hepatocellular carcinoma after radiofrequency thermal ablation. Nishikawa H; Osaki Y; Iguchi E; Koshikawa Y; Ako S; Inuzuka T; Takeda H; Nakajima J; Matsuda F; Sakamoto A; Henmi S; Hatamaru K; Ishikawa T; Saito S; Nasu A; Kita R; Kimura T J Clin Gastroenterol; 2013 Apr; 47(4):359-66. PubMed ID: 23090049 [TBL] [Abstract][Full Text] [Related]
13. Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma. Lam VW; Ng KK; Chok KS; Cheung TT; Yuen J; Tung H; Tso WK; Fan ST; Poon RT J Am Coll Surg; 2008 Jul; 207(1):20-9. PubMed ID: 18589357 [TBL] [Abstract][Full Text] [Related]
14. Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma. Lee S; Rhim H; Kim YS; Kang TW; Song KD Liver Int; 2016 Apr; 36(4):580-7. PubMed ID: 26503910 [TBL] [Abstract][Full Text] [Related]
15. Younger hepatocellular carcinoma patients have better prognosis after percutaneous radiofrequency ablation therapy. Kao WY; Chiou YY; Hung HH; Su CW; Chou YH; Huo TI; Huang YH; Wu WC; Lin HC; Lee SD; Wu JC J Clin Gastroenterol; 2012 Jan; 46(1):62-70. PubMed ID: 21934530 [TBL] [Abstract][Full Text] [Related]
16. Noninvasive fibrosis indices predict intrahepatic distant recurrence of hepatitis B-related hepatocellular carcinoma following radiofrequency ablation. Seo JY; Kim W; Kwon JH; Jin EH; Yu SJ; Kim HY; Jung YJ; Kim D; Kim YJ; Yoon JH; Lee HS Liver Int; 2013 Jul; 33(6):884-93. PubMed ID: 23461618 [TBL] [Abstract][Full Text] [Related]
17. Posthepatectomy HBV reactivation in hepatitis B-related hepatocellular carcinoma influences postoperative survival in patients with preoperative low HBV-DNA levels. Huang G; Lai EC; Lau WY; Zhou WP; Shen F; Pan ZY; Fu SY; Wu MC Ann Surg; 2013 Mar; 257(3):490-505. PubMed ID: 22868358 [TBL] [Abstract][Full Text] [Related]
18. High HBV-DNA titer in surrounding liver rather than in hepatocellular carcinoma tissue predisposes to recurrence after curative surgical resection. Choi JG; Chung YH; Kim JA; Jin YJ; Park WH; Lee D; Shim JH; Lee YS; Seo DD; Jang MK; Kim KM; Lim YS; Lee HC; Lee YS; Yu E; Lee YJ J Clin Gastroenterol; 2012; 46(5):413-9. PubMed ID: 22105184 [TBL] [Abstract][Full Text] [Related]
19. The preoperative positivity for serum hepatitis B e antigen did not affect overall survival after curative resection of hepatitis B virus-related hepatocellular carcinoma. Choi GH; Kim DH; Choi SB; Kang CM; Kim KS; Choi JS; Lee WJ; Han KH; Chon CY; Kim BR J Gastroenterol Hepatol; 2009 Mar; 24(3):391-8. PubMed ID: 19032452 [TBL] [Abstract][Full Text] [Related]
20. Topographical impact of hepatitis B-related hepatocellular carcinoma on local recurrence after radiofrequency ablation. Kim JS; Kim W; So YH; Yu SJ; Kim BG J Clin Gastroenterol; 2014 Jan; 48(1):66-72. PubMed ID: 23751848 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]